277 results
Page 6 of 14
8-K
b46 ndym3day7zn
30 Nov 20
GeoVax Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development
5:18pm
8-K
EX-99.1
69l jyok3
30 Nov 20
GeoVax Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development
5:18pm
8-K
EX-10.1
ewbbn
30 Nov 20
GeoVax Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development
5:18pm
424B3
00itvjgw
5 Nov 20
Prospectus supplement
5:17pm
8-K
fqczhbdgzcri6su1y
26 Oct 20
GeoVax Announces License Agreement with NIH
5:28pm
8-K
EX-10.1
wjedxxmfjnpz jh41y
26 Oct 20
GeoVax Announces License Agreement with NIH
5:28pm
8-K
EX-99.1
fiups6
26 Oct 20
GeoVax Announces License Agreement with NIH
5:28pm
D
fvizlf5 oh
7 Oct 20
$1.5M in equity / options, sold $1.5M, 8 investors
9:03pm
8-K
EX-4.1
hwc6mb 4mbcrv
29 Sep 20
GeoVax Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq
5:24pm
424B4
uw67 g8ojkf
28 Sep 20
Prospectus supplement with pricing info
4:56pm
8-K
EX-1.1
uxc6i dspruy2u
25 Sep 20
Entry into a Material Definitive Agreement
5:25pm
8-K
EX-10.1
zbt85
26 Aug 20
GeoVax Appoints Mark J. Newman, Ph.D. Chief Scientific Officer
5:16pm